Uses of Yolab

Yolab is a cardiovascular drug, belongs to the group of prescription drugs, the main ingredient in the drug is Gemfibrozil, a box containing 30 tablets in 3 blisters, manufactured in India. The drug has the effect of lowering blood fat, preventing cardiovascular diseases such as coronary heart disease, myocardial infarction,... For more information about Yolab, please read the following article.

Yolab drug has the active ingredient Gemfibrozil 600mg, prepared in the form of film-coated tablets, with good effects in hyperlipidemia thanks to the pharmacological mechanism of the main drug. Gemfibrozil is a drug for the treatment of dyslipidemia of the fibrates group. The drug reduces the synthesis of VLDL triglycerides in the liver by inhibiting peripheral lipolysis (by reducing fatty acids) and also reduces the incorporation of long-chain fatty acids. Thanks to that, the drug reduces the formation of LDL, the cause of atherosclerosis. The drug is very effective in reducing triglyceride levels, total cholesterol, bad LDL cholesterol, and good HDL cholesterol. Along with lipid-lowering effects, gemfibrozil also effectively reduces platelet aggregation, thereby reducing the risk of cardiovascular disease. After oral administration, the drug is rapidly absorbed from the gastrointestinal tract. Maximum plasma concentrations are reached 1 - 2 hours after oral administration. Gemfibrozil is about 97% protein bound, with a plasma half-life of about 1.5 hours. Yolab drug is mainly metabolized in the liver, excreted by the kidneys in the form of conjugates and unchanged active ingredients.

Yolab is indicated in:
Hyperlipidemia types IIa, IIb, III, IV & V unresponsive to diet, and using other appropriate modalities. Effective primary prevention of coronary heart disease, myocardial infarction in patients with hyperlipidemia or other dyslipidemia.

Do not use Yolab drug in the following contraindications:
Patients with hypersensitivity to the main active ingredient gemfibrozil and excipients. Patients with liver failure, gallbladder disease or kidney failure. Concomitant use of the drug with cerivastatin is contraindicated.

Usage : Yolab is used orally. Patients should take the drug with a full glass of water, take the medicine 30 minutes before a meal. Dosage: Yolab is used according to the doctor's prescription, or refer to the recommended dose as follows: Oral dose of 900 - 1200mg, divided equally 2 times before breakfast and dinner.

Side effects during taking Yolab are rare, such as signs of digestive disorders including nausea or vomiting, indigestion, allergic reactions and skin rashes.
Increased transaminases, bilirubin, decreased hemoglobin, decreased hematocrit and white blood cells in laboratory tests, rarely severe anemia, leukopenia, thrombocytopenia and marrow failure.

During the use of the drug, the patient should pay attention to the following issues:
When the patient is taking anticoagulants, please notify your treating doctor for drug interactions. Patients should have their blood lipids tested before and during treatment. If the results after 3 months of treatment are not up to the target, the drug should be discontinued.
Patients need periodic blood counts for about 1 year after drug treatment. The drug belongs to the group of toxic drugs in Group B, do not use Yolab for pregnant women, nursing mothers, do not use drugs. When there are signs of nausea and discomfort due to side effects of the drug, the patient needs to focus on driving or operating machinery. Above is information about Yolab drug, a group of drugs that reduce bad lipids in the blood. Patients should not arbitrarily use Yolab drugs without a prescription, should strictly follow the treatment guidelines of the doctor. If you read and have questions about the drug, you need to see pharmacists, medical experts for advice.